02/12/2026
We're glad to celebrate Dr. Michael Humeniuk and our oncology research team for their contributions to clinical trial A222001, recently published in the Journal of Clinical Oncology.
This study found that men with prostate cancer saw a significant reduction in hot flashes when treated with oxybutynin, an important step forward in survivorship and side-effect care.
Congratulations to Dr. Humeniuk and our investigators for helping advance the future of oncology care!
Read the full publication here: https://ascopubs.org/doi/10.1200/JCO-25-01486